Table 2.
The clinical characteristics of patients with celiac disease and IBD.
| Gender/age | IBD type/involvement | IBD duration/time between CD diagnosis and IBD diagnosis (years) | Therapy | Anti-TTG IGA (RU/ML) | Anti-EMA IGA (dilution) | Marsh score | Endoscopic findings |
|---|---|---|---|---|---|---|---|
| Female/38 | CrD/distal colon involvement | 9/8 | 5-ASA, methyl prednisolone, AZA | 20.20 | 1/32-1/100 | 3c | Bulbus and duodenum 2nd segment appear pale, edematous, atrophic, comb tooth appearance |
| Female/56 | CrD/terminal ileum | 11/11 | 5-ASA | <2 | 1/10-1/32 | 3b | Normal appearing duodenum |
| Female/77 | UC/distal colitis | 3/1 | 5-ASA | 55.87 | 1/320-1/1000 | 2 | Duodenum 2nd segment has comb sign |
| Female/31 | CrD/perianal fistula, colon involvement | 23/1 | 5-ASA, methyl prednisolone, azathioprine | 125.04 | 1/320-1/1000 | 3b | Duodenum 2nd segment has comb tooth appearance |
IBD: inflammatory bowel disease; CrD: Crohn's disease; UC: ulcerative colitis; CD: celiac disease; 5-ASA: 5 acetyl salicylic acid; AZA: azathioprine; RU/ML: relative unit/millilitre; anti-TTG: anti-tissue transglutaminase; anti-EMA: antiendomysium.